Abeona Therapeutics, Inc.
(NASDAQ : ABEO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. -3.04%194.241.9%$428.73m
TEVATeva Pharmaceutical Industries Ltd. -3.23%8.242.0%$77.15m
RDYDr. Reddy's Laboratories Ltd. -3.30%57.732.0%$5.35m
TXMDTherapeuticsMD, Inc. -4.34%0.3014.2%$2.30m
JAGXJaguar Health, Inc. -5.17%0.772.6%$1.61m
TAROTaro Pharmaceutical Industries Ltd. -2.53%45.116.6%$0.96m
ABEOAbeona Therapeutics, Inc. -4.74%0.222.5%$0.84m
COCPCocrystal Pharma, Inc. -9.36%0.480.0%$0.40m
LFVNLifeVantage Corp. 1.41%6.133.6%$0.28m
CPHIChina Pharma Holdings, Inc. -5.01%0.350.1%$0.10m

Company Profile

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.